EGCG and Omega-3 Fatty Acids Impact on Fatty Acid Synthase Activity in the Prosta
EGCG and Omega-3 Fatty Acids Impact on Fatty Acid Synthase Activity in the Prosta
批准号:
7478587
负责人:
JACKILEN SHANNON
金额:
$21.98万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-30 至 2011-09-29
关键词:
ADD-1 proteinAddressApoptosisApoptoticAwarenessBiological FactorsBiopsyCell DeathCell ProliferationClinical ResearchComplementary and alternative medicineDataDiagnosisDietDiseaseEpigallocatechin GallateFatty AcidsFatty-acid synthaseFish OilsGlandGreen teaGrowthHealth SciencesHistocompatibility TestingIn VitroInterventionIntervention StudiesInvestigationJointsLinkMalignant neoplasm of prostateMediatingMethodsNational Center for Complementary and Alternative MedicineNumbersOmega-3 Fatty AcidsOncogenicOregonPathway interactionsPlacebosPoliciesPrevention therapyProstateProstate-Specific AntigenProtein OverexpressionPurposeResearchResearch PersonnelRiskSafetySamplingScreening procedureSeverity of illnessStagingSupplementationTestingTextTimeTissuesUniversitiesVariantcancer diagnosiscancer riskcarcinogenesisdesiregallocatecholhigh risk menimprovedin vivoinnovationmenneoplasticneurophysiologyprogramsrandomized placebo controlled trialresponsetumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Prostate specific antigen (PSA) screening has vastly improved our ability to identify men at risk of prostate cancer and diagnose this disease at an early stage. But, of men who undergo prostate biopsy due to elevated PSA, only approximately 25% are diagnosed with prostate cancer. For those men with a negative biopsy, the awareness of their risk of prostate cancer has been raised dramatically, and there may be a strong desire to identify methods to reduce their risk of ultimately developing this disease. Many of these men may seek out complementary and alternative medicines (CAM) in an attempt to alter their risk of prostate cancer. A number of CAM compounds, including omega-3 fatty acids (omega-3 FA) and green tea catechins have been hypothesized to reduce prostate cancer risk. However, it is important to understand the biologic mechanism underlying how they may function to slow or inhibit prostate carcinogenesis. One particular biologic pathway, which may be altered by both omega -3 FA and the specific green tea catechin, epigallocatechin-3-gallate (EGCG), is the fatty acid synthase (FAS) pathway. FAS, a lipogenic multienzyme that catalyzes the final step in de novo fatty acid synthesis, has been shown to be highly expressed in prostate carcinogenesis, and has been correlated with greater disease severity. Both EGCG and omega-3 FA have been shown in vitro and in vivo to inhibit this overexpression of FAS.
The primary objective or our proposal is to elucidate in men at high risk for prostate cancer, a potential biologic mechanism whereby EGCG, alone or in combination with omega-3 FA, may alter cellular composition and growth, thereby reducing overall risk of prostate cancer. In the proposed GCRC sponsored, randomized, placebo-controlled study we will evaluate the independent and joint effect of EGCG and EGCG plus omega-3 FA on FAS expression, FAS activity, cell proliferation and apoptosis in bengin, pre-neoplastic and neoplastic prostate tissue of men undergoing repeat prostate biopsy.
Findings from this study will provide some of the first evidence linking the observed associations between factors modifiable by diet (primarily EGCG and omega-3 FA) and a specific biologic mechanism (FAS pathway) that is suggested to influence prostate carcinogenesis. The elucidation of a single oncogenic pathway that may be regulated by diet may provide a new and exciting opportunity for targeted prevention therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Measuring Gender in the Healthy Oregon Project
-
批准号:10794845
-
项目类别:
-
资助金额:$16.16万
-
财政年份:2023
-
负责人:JACKILEN SHANNON
-
依托单位:
THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE A NO-COST EXTENSION TO THE PERIOD OF PERFORMANCE.
-
批准号:10462228
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2021
-
负责人:JACKILEN SHANNON
-
依托单位:
Sulforaphane: A Dietary HDAC Inhibitor and Prevention of DCIS Progression
-
批准号:8019442
-
项目类别:
-
资助金额:$19.29万
-
财政年份:2009
-
负责人:JACKILEN SHANNON
-
依托单位:
Sulforaphane: A Dietary HDAC Inhibitor and Prevention of DCIS Progression
-
批准号:7588377
-
项目类别:
-
资助金额:$13.91万
-
财政年份:2009
-
负责人:JACKILEN SHANNON
-
依托单位:
Sulforaphane: A Dietary HDAC Inhibitor and Prevention of DCIS Progression
-
批准号:7758352
-
项目类别:
-
资助金额:$20.87万
-
财政年份:2009
-
负责人:JACKILEN SHANNON
-
依托单位:
EGCG and Omega-3 Fatty Acids Impact on Fatty Acid Synthase Activity in the Prosta
-
批准号:7212333
-
项目类别:
-
资助金额:$19.18万
-
财政年份:2006
-
负责人:JACKILEN SHANNON
-
依托单位:
EGCG and Omega-3 Fatty Acids Impact on Fatty Acid Synthase Activity in the Prosta
-
批准号:7295775
-
项目类别:
-
资助金额:$18.35万
-
财政年份:2006
-
负责人:JACKILEN SHANNON
-
依托单位:
DIETARY FATTY ACID INTAKE, COX-2 EXPRESSION AND RISK OF PROSTATE CANCER
-
批准号:7206577
-
项目类别:
-
资助金额:$0.37万
-
财政年份:2005
-
负责人:JACKILEN SHANNON
-
依托单位:
Diet and Prostate Cancer Risk
-
批准号:6794948
-
项目类别:
-
资助金额:$15.92万
-
财政年份:2003
-
负责人:JACKILEN SHANNON
-
依托单位:
Diet and Prostate Cancer Risk
-
批准号:6576095
-
项目类别:
-
资助金额:$15.91万
-
财政年份:2003
-
负责人:JACKILEN SHANNON
-
依托单位:
Diet and Prostate Cancer Risk
-
批准号:6910726
-
项目类别:
-
资助金额:$15.93万
-
财政年份:2003
-
负责人:JACKILEN SHANNON
-
依托单位:
Dietary fatty acid intake, COX-2 expression and risk of prostate cancer
-
批准号:6981106
-
项目类别:
-
资助金额:$0.31万
-
财政年份:2003
-
负责人:JACKILEN SHANNON
-
依托单位:
Community Outreach and Engagement
-
批准号:10411208
-
项目类别:
-
资助金额:$11.76万
-
财政年份:1997
-
负责人:JACKILEN SHANNON
-
依托单位:
Community Outreach and Engagement
-
批准号:10629327
-
项目类别:
-
资助金额:$11.76万
-
财政年份:1997
-
负责人:JACKILEN SHANNON
-
依托单位:
海外基金